Bull
$78.10
Scenario price
$60.780
+0.535 (+0.88%)At close
Fortive Corp innovates essential technologies to keep its world safe and productive. The Company’s segments include Intelligent Operating Solutions and Advanced Healthcare Solutions. Its Intelligent Operating Solutions segment provides advanced instrumentation, software and services to tens of thousands of customers, enabling their mission-critical workflows. These offerings include professional instruments used in applications including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications and electronics, among others. Its Advanced Healthcare Solutions segment supplies critical workflow solutions enabling healthcare providers to deliver patient care more efficiently. Its offerings include instrument sterilization solutions, and instrument tracking.
Fortive Corp (FTV) is currently priced at $60.25, which is near the analyst target of $60 from Evercore ISI. The stock has a high RSI of 81.42, indicating it may be overbought in the short term. The forward P/E ratio of 17.27 suggests reasonable future earnings expectations, but the recent insider selling has increased by 595.14%, which raises concerns about insider confidence. Given these factors, it may be prudent to hold rather than buy, as the stock could face short-term volatility.
JPMorgan
$56
2026-10-09
JPMorgan
2026-10-09
Price Target
$56
Truist
$63
2026-10-05
Truist
2026-10-05
Price Target
$63
Evercore ISI
$60
2026-09-28
Evercore ISI
2026-09-28
Price Target
$60
Truist
$67
2026-07-02
Truist
2026-07-02
Price Target
$67
Morgan Stanley
$59
2026-06-03
Morgan Stanley
2026-06-03
Price Target
$59
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Major Risks Loom for Stock Market Next Week Amid AI Trade Stumbles

Fluke Launches New Fiber Inspection Tools for High-Density Data Centers

Fluke Launches New Fiber Inspection Tools for High-Density Data Centers

Campus Safety Linked to Facility Maintenance and Emergency Preparedness

Fortive Appoints New Board Member Susan L. Main
Fortive Corp innovates essential technologies to keep its world safe and productive. The Company’s segments include Intelligent Operating Solutions and Advanced Healthcare Solutions. Its Intelligent Operating Solutions segment provides advanced instrumentation, software and services to tens of thousands of customers, enabling their mission-critical workflows. These offerings include professional instruments used in applications including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications and electronics, among others. Its Advanced Healthcare Solutions segment supplies critical workflow solutions enabling healthcare providers to deliver patient care more efficiently. Its offerings include instrument sterilization solutions, and instrument tracking. It operates in the Industrials sector (INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, A industry).
Fortive Corp (FTV) is currently priced at $60.25, which is near the analyst target of $60 from Evercore ISI. The stock has a high RSI of 81.42, indicating it may be overbought in the short term. The forward P/E ratio of 17.27 suggests reasonable future earnings expectations, but the recent insider selling has increased by 595.14%, which raises concerns about insider confidence. Given these factors, it may be prudent to hold rather than buy, as the stock could face short-term volatility.
18 analysts cover FTV: 8 rate it Buy, 10 Hold and 0 Sell. The average price target is 59.30.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.